ABSTRACT Specific binding sites for the regulatory subunit of type II cAMP-dependent protein Idnase (RI,) were revealed in neurons by an immunohistochemical approach. Fixed frozen sections of several regions of the rat central nervous system were incubated in the presence of bovine RI,. Bound bovine RH1 was subsequently detected by an immunofluorescence procedure using antibodies that recognize bovine but not rat RI,. The Following the discovery of neurotransmitter-sensitive adenylate cyclases (1), much evidence that cAMP plays an important modulatory role in neurons has accumulated (2). cAMP-dependent protein kinases, the target enzymes for cAMP, are present at high concentrations in all regions of the central nervous system (3, 4). At the subcellular level, however, they seem to be at least partially compartmentalized because such kinase activities have been demonstrated in both soluble and particulate subfractions (3-9). One of the possible mechanisms of compartmentalization is a high-affinity interaction of their subunits with partner molecules localized on structural cellular components. An association of type II cAMP-dependent protein kinases with specific cytoplasmic proteins, mediated by its regulatory subunit, RI,, has recently been reported (10-12).
Following the discovery of neurotransmitter-sensitive adenylate cyclases (1) , much evidence that cAMP plays an important modulatory role in neurons has accumulated (2) . cAMP-dependent protein kinases, the target enzymes for cAMP, are present at high concentrations in all regions of the central nervous system (3, 4) . At the subcellular level, however, they seem to be at least partially compartmentalized because such kinase activities have been demonstrated in both soluble and particulate subfractions (3) (4) (5) (6) (7) (8) (9) . One of the possible mechanisms of compartmentalization is a high-affinity interaction of their subunits with partner molecules localized on structural cellular components. An association of type II cAMP-dependent protein kinases with specific cytoplasmic proteins, mediated by its regulatory subunit, RI,, has recently been reported (10) (11) (12) .
In the present work we used an immunohistochemical approach to study the existence and distribution of high-affinity binding sites for RI, in the central nervous system ofthe rat. For this purpose we took advantage of the antigenic dissimilarity between bovine and rat RI, (13) . Antibodies raised against bovine RII did not stain any cellular element when used to label endogenous RI, in rat brain by immunofluorescence. It therefore has been possible to study binding sites for RI, by using bovine RI, as a probe followed by the anti-bovine RI, antibodies tolocalize the bound exogenous RI,. The starting premise ofthis work was that, in spite of the prominent antigenic differences between bovine and rat RI,, physiologically important binding sites on these two molecules for other cytoplasmic proteins might be similar.
Results presented here indicate that RI, binds specifically to neurons and that, in neurons, binding is most prominent in dendrites. They also suggest that such binding is probably mediated by microtubule-associated protein 2 (MAP 2), a high molecular weight protein that copurifies with brain microtubules (14, 15) and is a prominent substrate for cAMP-dependent protein kinase.
MATERIALS AND METHODS
Preparation of Antigens and Antibodies. Bovine heart RI, was prepared and used to immunize rabbits as described (9) . Some of the characteristics of the antiserum thus obtained are described in refs. 9, 13, and 16 . Antibodies specific for RI, were prepared from the serum by affinity-chromatography on bovine heart RI, covalently bound to Sepharose beads (Pharmacia, Uppsala, Sweden). Specific antibodies were eluted from the beads by pH 2.3 buffer.
A MAP fraction highly enriched in MAP 2 and devoid of MAP 1 (heat-stable MAP fraction) was prepared by exposure offour times-cycled microtubules (from bovine cerebral cortex) to heat (17) (18) (19) . MAP 2 represented 75% of the total protein content of the fraction (unpublished data). For the preparation of a specific antiserum directed, against MAP 2, peptides contained in the crude MAP fraction were separated by NaDodSO4/ polyacrylamide slab gel electrophoresis. The MAP 2-containing region of the gel was then excised and injected into rabbits. When tested by gel radioimmunolabeling (20) against all the peptides contained in a homogenate ofrat brain, the antiserum recognized only the MAP 2 doublet (unpublished data).
Gel Electrophoresis and Gel Radioimmunolabeling. NaDodSO4/polyacrylamide slab gel electrophoresis of homogenates of rat and bovine brains was performed as described (20) . Gels were radioimmunolabeled as described (20) , with the exception that affinity-purified antibodies directed against RI, instead of whole serum were used at the primary step of the procedure. Immunohistochemical Procedures. Tissues were fixed and frozen sections were prepared as reported (21) . In all cases, tissues were frozen by quick immersion in isopentane chilled with liquid nitrogen. Immunohistochemical staining was performed as described (21) All protein-containing solutions were cleared by centrifugation in an Eppendorf Microfuge before being applied to tissue sections.
RESULTS
Immunological Dissimilarity Between Rat and Bovine RII.
When, affinity-purified antibodies raised against bovine RI, were used to immunolabel gels of bovine brain homogenate, only the doublet of RI, (9) was labeled ( Fig. 1) enate was used instead of bovine brain homogenate (Fig. 2) . Similar results, indicating poor imunological crossreactivity between bovine and rat R11, have been obtained by immunoprecipitation (13) .
Binding of RI, to Tissue Sections. When the affinity-purified antibodies directed against bovine RI, were used to stain frozen sections of formaldehyde-fixed rat brain by an indirect immunorhodamine procedure, no specific staining was detected (Fig.  3a) . Results were indistinguishable from those obtained when the anti-RI, antibodies were replaced by preimmune serum or nonimmune IgGs. This was not surprising in view of the low crossreactivity between rat and bovine RI, mentioned above.
However, a bright fluorescence was observed in sections immunostained with affinity-purified antibovine RI, antibodies when the immunohistochemical procedure was preceded by incubation of the sections with bovine RI, (Figs. 3 and 4 a and d). This fluorescence had a typical pattern: (a) it was present in all regions of the gray matter; (b) it was specifically localized in neurons and outlined them; glial cells were unstained; (c) inside neurons it was unevenly distributed-fluorescence generally was bright in dendrites, present but to a lower and variable extent in perikarya, absent from nuclei, and undetectable in axons and axon terminals. Staining intensity was variable in different regions of the central nervous system. For instance, staining of dendrites was bright in the gray matter of the brain stem (Figs. 3 b and c and 4d ) and the spinal cord but weak in the cerebellar cortex (not shown).
Because our antibodies directed against RI, did not recognize endogenous RI, in rat tissue sections, the staining described above has to be attributed to the exogenous bound bovine RI,. Such Specific binding of bovine RI, to rat tissue sections was unaffected by the presence of a high concentration of cAMP in the incubation medium (Fig. 3 d and e) .
The Morphological Distribution of Binding Sites for RI, Is
Similar to the Morphological Distribution of MAP 2 Immunoreactivity. It has recently been reported that high molecular weight MAPs are highly compartmentalized in brain, being mostly concentrated in neuronal dendrites (24) . Analogous results have been obtained with an antiserum specific for MAP 2 (unpublished data). When the morphological distributions of RI, binding sites and of MAP 2 immunoreactivity were compared, an almost identical pattern could be recognized in all of the several regions of the central nervous system we have examined, which include hippocampus ( Fig. 3f and g ), cerebral cortex (Fig. 4 a and b) (b-f) Sections processed as described for a, after a preincubation in the presence of purified bovine heart RH. Also, binding sites of low affinity, not detectable by our experimental protocol, might be important physiologically in cells containing high concentrations of RI,. Finally, it should be stressed that in our study we used an RI, subunit purified from heart. It is well known that differences exist between brain and heart RI, (8, 9) and that, when analyzed by NaDodSO4 gel electrophoresis, brain RI, appears to consist ofa heterogeneous population of peptides of similar molecular weight (9) (Figs. 1 and   2 ). It is possible that the ability to bind to neuronal dendrites is peculiar to a subclass of RI, molecules common to brain and heart. Other RI, subclasses, specific to brain, might bind to other structures. This question will be clarified by studying the specific interaction with brain tissue of RI, purified from brain.
It will be interesting in the future to study whether specific binding sites exist for RI, the regulatory subunit oftype I cAMPdependent protein kinase, and whether these binding sites are distinct from those for RI,. In fact, binding sites specific for either RI or RI, might be the basis for the functional difference between the two regulatory subunits. They might mediate the intracellular compartmentalization of the catalytic subunit in distinct supramolecular structures.
